Joshua Reed - 30 Mar 2022 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role: Chief Financial Officer
Signature: /s/ Joshua Reed
Issuer symbol: ALDX
Transactions as of: 30 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Apr 2022, 19:37:15 UTC
Next filing: 02 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALDX	Common Stock	Award	$0	+93,322	+51%	$0.000000	274,825	30 Mar 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALDX	Employee Stock Option (Right to Buy)	Award	$0	+250,000		$0.000000	250,000	30 Mar 2022	Common Stock	250,000	$4.52	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
F2	Includes 8,022 shares previously purchased under the Issuer's Employee Stock Purchase Plan.
F3	The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022.